Cushing syndrome: a review

M Reincke, M Fleseriu - Jama, 2023 - jamanetwork.com
Importance Cushing syndrome is defined as a prolonged increase in plasma cortisol levels
that is not due to a physiological etiology. Although the most frequent cause of Cushing …

Hypopituitarism

M Fleseriu, M Christ-Crain, F Langlois, M Gadelha… - The Lancet, 2024 - thelancet.com
Partial or complete deficiency of anterior or posterior pituitary hormone production leads to
central hypoadrenalism, central hypothyroidism, hypogonadotropic hypogonadism, growth …

Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset

M Luo, R Tang, H Wang - Journal of Neuro-Oncology, 2023 - Springer
Purpose Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs) and
application of current immunotherapy for refractory PitNETs remains debated. We aim to …

Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: a systematic review

R Hamblin, N Karavitaki - Archives of Medical Research, 2023 - Elsevier
Background The increased prevalence of Impulse Control Disorders (ICDs) in dopamine
agonist (DA) treated patients with Parkinson's disease is well described. Despite the …

[HTML][HTML] Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management

F Ebrahimi, L Andereggen, ER Christ - Reviews in Endocrine and …, 2024 - Springer
Hypopituitarism is a highly heterogeneous multisystem disorder that can have a major
impact on long-term morbidity and mortality, but even more so during acute medical …

FLNA expression modulates pathological markers of pituitary neuroendocrine tumours

J Toledo, PA Perez, M Zanetti… - Journal of …, 2024 - joe.bioscientifica.com
Due to the current limited knowledge about the role of filamin A (FLNA) in pituitary tumour
progression, we aimed to analyse FLNA expression levels and its impact on aggressive …

Common and uncommon mouse models of growth hormone deficiency

EO List, R Basu, DE Berryman, S Duran-Ortiz… - Endocrine …, 2024 - academic.oup.com
Mouse models of growth hormone deficiency (GHD) have provided important tools for
uncovering the various actions of GH. Nearly 100 years of research using these mouse lines …

[HTML][HTML] An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of …

AS Alzahrani, A Bin Nafisah, M Alswailem… - Frontiers in …, 2023 - frontiersin.org
Context Germline succinate dehydrogenase subunit B (SDHB) pathogenic variants are
characteristic of familial paraganglioma (PGL) syndrome type 4. This syndrome frequently …

Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors

X Guo, Y Yang, Z Qian, M Chang, Y Zhao, W Ma… - Cancer Letters, 2024 - Elsevier
Pituitary neuroendocrine tumors (pitNETs) are the second most common primary brain
tumors. Despite their prevalence, the tumor immune microenvironment (TIME) and its clinical …

[HTML][HTML] Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma

Y Cai, S Liu, X Zhao, L Ren, X Liu, X Gang… - Frontiers in …, 2024 - frontiersin.org
Plurihormonal pituitary adenoma (PPA) is a type of pituitary tumor capable of producing two
or more hormones and usually presents as an aggressive, large adenoma. As yet, its …